标题
The ongoing pursuit of neuroprotective therapies in Parkinson disease
作者
关键词
-
出版物
Nature Reviews Neurology
Volume 11, Issue 1, Pages 25-40
出版商
Springer Nature
发表日期
2014-12-02
DOI
10.1038/nrneurol.2014.226
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease
- (2015) Iciar Aviles-Olmos et al. Journal of Parkinsons Disease
- Exenatide as a potential treatment for patients with Parkinson's disease: First steps into the clinic
- (2014) Thomas Foltynie et al. Alzheimers & Dementia
- Serum Urate and the Risk of Parkinson's Disease: Results From a Meta-Analysis
- (2014) Chunhong Shen et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Latest treatment options for Alzheimer’s disease, Parkinson’s disease dementia and dementia with Lewy bodies
- (2014) Martin Broadstock et al. EXPERT OPINION ON PHARMACOTHERAPY
- Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity
- (2014) Cliona Stack et al. HUMAN MOLECULAR GENETICS
- Simvastatin prevents neuroinflammation by inhibiting N-methyl-D-aspartic acid receptor 1 in 6-hydroxydopamine-treated PC12 cells
- (2014) Junqiang Yan et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives
- (2014) Anthony H V Schapira et al. LANCET
- Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy
- (2014) Tara L. Spires-Jones et al. NEUROSCIENCE LETTERS
- A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy
- (2014) Franziska Richter et al. Neurotherapeutics
- Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life
- (2014) Rachael A. Lawson et al. PARKINSONISM & RELATED DISORDERS
- Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease
- (2014) Gergely Tóth et al. PLoS One
- Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation
- (2014) B I Pérez-Revuelta et al. Cell Death & Disease
- Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease
- (2014) Michael A. Schwarzschild et al. JAMA Neurology
- A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease
- (2014) et al. JAMA Neurology
- Neuropathology of cigarette smoking
- (2013) Raymond Chuen-Chung Chang et al. ACTA NEUROPATHOLOGICA
- Clinical effects of once-weekly exenatide for the treatment of type 2 diabetes mellitus
- (2013) G. J. Ryan et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
- (2013) David Devos et al. ANTIOXIDANTS & REDOX SIGNALING
- Mitochondria-targeted antioxidants for treatment of Parkinson's disease: Preclinical and clinical outcomes
- (2013) Huajun Jin et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson’s disease
- (2013) Heather Mortiboys et al. BRAIN
- Parkinson’s disease is associated with altered expression of CaV1 channels and calcium-binding proteins
- (2013) Michael J. Hurley et al. BRAIN
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- Clinical Proof-of-Concept Study With MSDC-0160, a Prototype mTOT-Modulating Insulin Sensitizer
- (2013) J R Colca et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?
- (2013) A. Consoli et al. DIABETES OBESITY & METABOLISM
- Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies
- (2013) M. Ferwana et al. DIABETIC MEDICINE
- Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: Possible role of SOCS-1 in reducing pro-inflammatory responses
- (2013) Dario D Lofrumento et al. Innate Immunity
- Exenatide and the treatment of patients with Parkinson’s disease
- (2013) Iciar Aviles-Olmos et al. JOURNAL OF CLINICAL INVESTIGATION
- Parkinson’s disease: an update on pathogenesis and treatment
- (2013) Tom Foltynie et al. JOURNAL OF NEUROLOGY
- Safety and efficacy of recombinant human erythropoietin treatment of non-motor symptoms in Parkinson's disease
- (2013) Wooyoung Jang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Primary sleep disorder prevalence in patients with newly diagnosed Parkinson's disease
- (2013) Benjamin Prudon et al. MOVEMENT DISORDERS
- Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms
- (2013) Gordon W. Duncan et al. MOVEMENT DISORDERS
- Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD)
- (2013) MOVEMENT DISORDERS
- Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
- (2013) David J. Irwin et al. NATURE REVIEWS NEUROSCIENCE
- Longitudinal changes in sulcal morphology associated with late-life aging and MCI
- (2013) Tao Liu et al. NEUROIMAGE
- Discontinuation of statin therapy associates with Parkinson disease: A population-based study
- (2013) Y.-C. Lee et al. NEUROLOGY
- Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats
- (2013) Rasool Haddadi et al. NEUROSCIENCE LETTERS
- Modeling Lewy pathology propagation in Parkinson's disease
- (2013) Kelvin C. Luk et al. PARKINSONISM & RELATED DISORDERS
- Identification of a Mitochondrial Target of Thiazolidinedione Insulin Sensitizers (mTOT)—Relationship to Newly Identified Mitochondrial Pyruvate Carrier Proteins
- (2013) Jerry R. Colca et al. PLoS One
- Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies
- (2013) S. Pablo Sardi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification and Rescue of -Synuclein Toxicity in Parkinson Patient-Derived Neurons
- (2013) C. Y. Chung et al. SCIENCE
- Yeast Reveal a "Druggable" Rsp5/Nedd4 Network that Ameliorates -Synuclein Toxicity in Neurons
- (2013) D. F. Tardiff et al. SCIENCE
- Use of Calcium Channel Blockers and Parkinson’s Disease
- (2012) Björn Pasternak et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Neuropathologic substrates of Parkinson disease dementia
- (2012) David J. Irwin et al. ANNALS OF NEUROLOGY
- Prospective Study of Statin Use and Risk of Parkinson Disease
- (2012) Xiang Gao ARCHIVES OF NEUROLOGY
- Pathologic Accumulation of α-Synuclein and Aβ in Parkinson Disease Patients With Dementia
- (2012) Paul T. Kotzbauer et al. ARCHIVES OF NEUROLOGY
- Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease
- (2012) Ari Zimran et al. BLOOD CELLS MOLECULES AND DISEASES
- Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase
- (2012) Inna Bendikov-Bar et al. BLOOD CELLS MOLECULES AND DISEASES
- Zonisamide Attenuates MPP(+)-Induced Oxidative Toxicity Through Modulation of Ca2+ Signaling and Caspase-3 Activity in Neuronal PC12 Cells
- (2012) Vedat Ali Yürekli et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Zonisamide up-regulated the mRNAs encoding astrocytic anti-oxidative and neurotrophic factors
- (2012) ME Choudhury et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1
- (2012) David G Parkes et al. Expert Opinion on Drug Discovery
- Animal models of Parkinson’s disease
- (2012) Fabio Blandini et al. FEBS Journal
- The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice
- (2012) B. Zhang et al. JOURNAL OF NEUROSCIENCE
- A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients
- (2012) Jay S. Schneider et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain
- (2012) J W Steele et al. MOLECULAR PSYCHIATRY
- Biomarkers for trials of neuroprotection in Parkinson's disease
- (2012) Pankaj A. Agarwal et al. MOVEMENT DISORDERS
- Overcoming obstacles in Parkinson's disease
- (2012) Todd B. Sherer et al. MOVEMENT DISORDERS
- Design innovations and baseline findings in a long-term Parkinson's trial: The national institute of neurological disorders and stroke exploratory trials in Parkinson's Disease Long-Term Study-1
- (2012) Jordan J. Elm et al. MOVEMENT DISORDERS
- Pathogenesis of Parkinson's disease
- (2012) Etienne C. Hirsch et al. MOVEMENT DISORDERS
- Nicotine as a potential neuroprotective agent for Parkinson's disease
- (2012) Maryka Quik et al. MOVEMENT DISORDERS
- Inflammation in Parkinson's disease: Cause or consequence?
- (2012) Stanley H. Appel MOVEMENT DISORDERS
- Trial designs used to study neuroprotective therapy in Parkinson's disease
- (2012) Anthony E. Lang et al. MOVEMENT DISORDERS
- Genetic influences on cognitive decline in Parkinson's disease
- (2012) James F. Morley et al. MOVEMENT DISORDERS
- Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies
- (2012) Erwan Bezard et al. MOVEMENT DISORDERS
- The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease
- (2012) Raquel Duran et al. MOVEMENT DISORDERS
- RETRACTED: Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson’s disease with combined noradrenergic and serotonergic lesions
- (2012) N. Rampersaud et al. NEUROPEPTIDES
- Modulating Microglia Activity with PPAR-γ Agonists: A Promising Therapy for Parkinson’s Disease?
- (2012) Anna R. Carta et al. NEUROTOXICITY RESEARCH
- Actigraphic study of tremor before and after treatment with zonisamide in patients with Parkinson's disease
- (2012) Soichiro Mochio et al. PARKINSONISM & RELATED DISORDERS
- Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
- (2012) Mark L. Wahlqvist et al. PARKINSONISM & RELATED DISORDERS
- Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration
- (2012) X. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease
- (2012) Soosung Kang et al. Nature Communications
- The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
- (2012) L. Azoulay et al. BMJ-British Medical Journal
- Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer’s disease by exendin-4
- (2011) Song Chen et al. AGE
- Neuroprotective effects of creatine
- (2011) M. Flint Beal AMINO ACIDS
- Dihydropyridine calcium channel blockers and the progression of parkinsonism
- (2011) Connie Marras et al. ANNALS OF NEUROLOGY
- Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer Disease
- (2011) Pierre N. Tariot ARCHIVES OF GENERAL PSYCHIATRY
- Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
- (2011) Y. Compta et al. BRAIN
- Zonisamide-induced long-lasting recovery of dopaminergic neurons from MPTP-toxicity
- (2011) Mohammed Emamussalehin Choudhury et al. BRAIN RESEARCH
- Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease
- (2011) Gokhan K. Ulusoy et al. BRAIN RESEARCH BULLETIN
- Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease
- (2011) Susan Duty et al. BRITISH JOURNAL OF PHARMACOLOGY
- Alternative Mitochondrial Electron Transfer as a Novel Strategy for Neuroprotection
- (2011) Yi Wen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
- (2011) Christian Hansen et al. JOURNAL OF CLINICAL INVESTIGATION
- The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
- (2011) Christine R Swanson et al. Journal of Neuroinflammation
- Enhanced Phosphatase Activity Attenuates -Synucleinopathy in a Mouse Model
- (2011) K.-W. Lee et al. JOURNAL OF NEUROSCIENCE
- Prion-like acceleration of a synucleinopathy in a transgenic mouse model
- (2011) Anne-Laure Mougenot et al. NEUROBIOLOGY OF AGING
- The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease
- (2011) E. Ilijic et al. NEUROBIOLOGY OF DISEASE
- Mice Lacking Major Brain Gangliosides Develop Parkinsonism
- (2011) Gusheng Wu et al. NEUROCHEMICAL RESEARCH
- Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
- (2011) Laura A. Volpicelli-Daley et al. NEURON
- Vaccination for Parkinson's disease
- (2011) A. Schneeberger et al. PARKINSONISM & RELATED DISORDERS
- Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
- (2011) Eliezer Masliah et al. PLoS One
- A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease
- (2011) et al. PLoS Genetics
- Genome-Wide Association Study Confirms SNPs inSNCAand theMAPTRegion as Common Risk Factors for Parkinson Disease
- (2010) Todd L. Edwards et al. ANNALS OF HUMAN GENETICS
- N-acetylcysteine prevents loss of dopaminergic neurons in theEAAC1−/−mouse
- (2010) Ari E. Berman et al. ANNALS OF NEUROLOGY
- Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease
- (2010) Mohd.Moshahid Khan et al. BRAIN RESEARCH
- An introduction to adaptive designs and adaptation in CNS trials
- (2010) Vladimir Dragalin EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson’s disease after peripheral administration
- (2010) David T. Dexter et al. JOURNAL OF NEURAL TRANSMISSION
- The relevance of iron in the pathogenesis of Parkinson’s disease
- (2010) Jeswinder Sian-Hülsmann et al. JOURNAL OF NEUROCHEMISTRY
- GM1 ganglioside in Parkinson's disease: Results of a five year open study
- (2010) Jay S. Schneider et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden
- (2010) John C O'Leary et al. Molecular Neurodegeneration
- Artistic profession: A potential risk factor for dopamine dysregulation syndrome in Parkinson's disease?
- (2010) Petra Schwingenschuh et al. MOVEMENT DISORDERS
- Statin use and Parkinson's disease in Denmark
- (2010) Beate Ritz et al. MOVEMENT DISORDERS
- A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease
- (2010) Barry J. Snow et al. MOVEMENT DISORDERS
- A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease
- (2010) C. Savio Chan et al. MOVEMENT DISORDERS
- CSF Aβ42and tau in Parkinson's disease with cognitive impairment
- (2010) Thomas J. Montine et al. MOVEMENT DISORDERS
- Molecular and clinical prodrome of Parkinson disease: implications for treatment
- (2010) Anthony H. V. Schapira et al. Nature Reviews Neurology
- Oral N-Acetyl-Cysteine Attenuates Loss of Dopaminergic Terminals in α-Synuclein Overexpressing Mice
- (2010) Joanne Clark et al. PLoS One
- Hyperuricemia and incident hypertension: A systematic review and meta-analysis
- (2010) Peter C. Grayson et al. ARTHRITIS CARE & RESEARCH
- Modeling Parkinson's disease
- (2009) C. Warren Olanow et al. ANNALS OF NEUROLOGY
- Neuroprotective effects of zonisamide target astrocyte
- (2009) Masato Asanuma et al. ANNALS OF NEUROLOGY
- Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
- (2009) Alberto Ascherio ARCHIVES OF NEUROLOGY
- Nicotinic Receptor-Mediated Neuroprotection in Neurodegenerative Disease Models
- (2009) Shun Shimohama BIOLOGICAL & PHARMACEUTICAL BULLETIN
- A clinico-pathological study of subtypes in Parkinson's disease
- (2009) M. Selikhova et al. BRAIN
- Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
- (2009) Juliane Neumann et al. BRAIN
- Association Between Lifetime Cigarette Smoking and Lewy Body Accumulation
- (2009) Debby Tsuang et al. BRAIN PATHOLOGY
- Serum uric acid levels in patients with Parkinson's disease: Their relationship to treatment and disease duration
- (2009) Elisabeth Andreadou et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Zocor Forte® (simvastatin) has a neuroprotective effect against LPS striatal dopaminergic terminals injury, whereas against MPP+ does not
- (2009) Marti Santiago et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease
- (2009) Sehee Kim et al. JOURNAL OF ENDOCRINOLOGY
- Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease
- (2009) Robert A. Hauser et al. MOVEMENT DISORDERS
- Genome-wide association study reveals genetic risk underlying Parkinson's disease
- (2009) Javier Simón-Sánchez et al. NATURE GENETICS
- Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss
- (2009) Luke S Tain et al. NATURE NEUROSCIENCE
- Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of Parkinson's disease
- (2009) Jing Pan et al. NEUROCHEMISTRY INTERNATIONAL
- The Delayed-Start Study Design
- (2009) Ralph B. D'Agostino NEW ENGLAND JOURNAL OF MEDICINE
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- The MitoPark Mouse – An animal model of Parkinson's disease with impaired respiratory chain function in dopamine neurons
- (2009) Mats I. Ekstrand et al. PARKINSONISM & RELATED DISORDERS
- [11C]-PK11195 PET: Quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?
- (2009) A.L. Bartels et al. PARKINSONISM & RELATED DISORDERS
- Inclusion formation and neuronal cell death through neuron-to-neuron transmission of -synuclein
- (2009) P. Desplats et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of Pioglitazone, a Peroxisome Proliferator–Activated Receptor Gamma Agonist, on the Urine and Urothelium of the Rat
- (2009) Shugo Suzuki et al. TOXICOLOGICAL SCIENCES
- O3-04-07: Tau aggregation inhibitor (TAI) therapy with rember™ arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks
- (2008) Claude M. Wischik et al. Alzheimers & Dementia
- Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease
- (2008) Michael A. Schwarzschild ARCHIVES OF NEUROLOGY
- Smoking and Parkinson's disease: Does nicotine affect α-synuclein fibrillation?
- (2008) Dong-Pyo Hong et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease
- (2008) Soon-Tae Lee et al. BRAIN RESEARCH
- Use of Statins and the Risk of Parkinson???s Disease
- (2008) Claudia Becker et al. DRUG SAFETY
- PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson’s disease
- (2008) Naomi P. Visanji et al. FASEB JOURNAL
- Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells
- (2008) Francisco Molina-Holgado et al. JOURNAL OF NEUROCHEMISTRY
- Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide
- (2008) María del Carmen Hernández-Romero et al. JOURNAL OF NEUROCHEMISTRY
- Statins reduce neuronal α-synuclein aggregation in in vitro models of Parkinson’s disease
- (2008) Pazit Bar-On et al. JOURNAL OF NEUROCHEMISTRY
- Glucagon-like peptide 1 receptor stimulation by exendin-4 reverses key deficits in distinct rodent models of Parkinson's disease
- (2008) Alexander Harkavyi et al. Journal of Neuroinflammation
- Mitochondria in the aetiology and pathogenesis of Parkinson's disease
- (2008) Anthony HV Schapira LANCET NEUROLOGY
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
- (2008) Mariese A. Hely et al. MOVEMENT DISORDERS
- Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
- (2008) Jia-Yi Li et al. NATURE MEDICINE
- Statin use and the risk of Parkinson disease
- (2008) A. D. Wahner et al. NEUROLOGY
- Use of antihypertensives and the risk of Parkinson disease
- (2008) C. Becker et al. NEUROLOGY
- Neurochemical pathways involved in the protective effects of nicotine and ethanol in preventing the development of Parkinson's disease: Potential targets for the development of new therapeutic agents
- (2008) Roberta J. Ward et al. PROGRESS IN NEUROBIOLOGY
- Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of parkinson's disease
- (2007) Göran Bertilsson et al. JOURNAL OF NEUROSCIENCE RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started